Effect of probiotics during vonoprazan‐containing triple therapy on gut microbiota in <i>Helicobacter pylori</i> infection: A randomized controlled trial

Abstract

Biofermin-R combined with VPZ-based therapy resulted in higher microbial α-strain diversity and suppressed stool softening during H pylori eradication therapy.